Arghya Ray

5.7k total citations
76 papers, 2.9k citations indexed

About

Arghya Ray is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Arghya Ray has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 44 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Arghya Ray's work include Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (21 papers) and Ubiquitin and proteasome pathways (18 papers). Arghya Ray is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (21 papers) and Ubiquitin and proteasome pathways (18 papers). Arghya Ray collaborates with scholars based in United States, Switzerland and India. Arghya Ray's co-authors include Bengt Nordén, James D. Griffin, Ellen Weisberg, Dharminder Chauhan, Kenneth C. Anderson, Paul W. Manley, Sandra W. Cowan‐Jacob, Yan Song, J. Mestan and Paul G. Richardson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Arghya Ray

72 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arghya Ray United States 30 1.8k 1.1k 683 546 272 76 2.9k
Darren R. Veach United States 26 1.5k 0.8× 1.3k 1.3× 1.0k 1.5× 849 1.6× 543 2.0× 58 4.0k
Warren Fiskus United States 48 5.1k 2.8× 1.7k 1.6× 1.2k 1.7× 818 1.5× 223 0.8× 141 6.3k
Richard L. Momparler Canada 43 4.4k 2.4× 1.0k 0.9× 847 1.2× 293 0.5× 70 0.3× 122 5.5k
Stefan Nagel Germany 31 1.3k 0.7× 592 0.6× 721 1.1× 247 0.5× 57 0.2× 125 2.9k
H. Trent Spencer United States 31 1.3k 0.7× 523 0.5× 1.3k 1.9× 184 0.3× 65 0.2× 120 2.6k
Arthur J. Chirino United States 15 1.7k 0.9× 563 0.5× 237 0.3× 357 0.7× 53 0.2× 15 3.2k
Steven Rosenberg United States 27 1.8k 1.0× 1.0k 1.0× 636 0.9× 296 0.5× 62 0.2× 49 4.1k
Maria G. Pallavicini United States 27 1.8k 1.0× 617 0.6× 877 1.3× 348 0.6× 35 0.1× 81 3.6k
Staffan Magnusson Denmark 33 1.7k 0.9× 816 0.8× 378 0.6× 266 0.5× 420 1.5× 62 3.8k
Robert A. Copeland United States 33 4.3k 2.4× 402 0.4× 508 0.7× 150 0.3× 45 0.2× 66 5.0k

Countries citing papers authored by Arghya Ray

Since Specialization
Citations

This map shows the geographic impact of Arghya Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arghya Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arghya Ray more than expected).

Fields of papers citing papers by Arghya Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arghya Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arghya Ray. The network helps show where Arghya Ray may publish in the future.

Co-authorship network of co-authors of Arghya Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Arghya Ray. A scholar is included among the top collaborators of Arghya Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arghya Ray. Arghya Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Teng, Yan Song, Ting Du, et al.. (2024). 26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma. Blood. 144(Supplement 1). 1905–1905.
2.
Ray, Arghya, Yan Song, Ting Du, et al.. (2024). Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples. Blood. 144(Supplement 1). 1947–1947. 1 indexed citations
3.
Ray, Arghya, Yan Song, Ting Du, et al.. (2022). Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma. Blood Cancer Journal. 12(4). 50–50. 11 indexed citations
4.
Song, Yan, Paul M.C. Park, Lei Wu, et al.. (2019). Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma. Leukemia. 33(11). 2685–2694. 31 indexed citations
5.
Ray, Arghya, Yan Song, Ting Du, et al.. (2019). Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma. Leukemia. 34(2). 567–577. 25 indexed citations
6.
Das, Deepika Sharma, Abhishek Das, Arghya Ray, et al.. (2017). Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells. Clinical Cancer Research. 23(15). 4280–4289. 78 indexed citations
7.
Ray, Arghya, Deepika Sharma Das, Yan Song, Dharminder Chauhan, & Kenneth C. Anderson. (2017). Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma. Blood. 130. 1792–1792. 1 indexed citations
8.
Das, Deepika Sharma, Arghya Ray, Abhishek Das, et al.. (2016). A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells. Leukemia. 30(11). 2187–2197. 68 indexed citations
9.
Chauhan, Dharminder, Arghya Ray, Kristina Viktorsson, et al.. (2013). In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells. Clinical Cancer Research. 19(11). 3019–3031. 79 indexed citations
10.
Weisberg, Ellen, Arghya Ray, Erik A. Nelson, et al.. (2011). Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells. PLoS ONE. 6(9). e25351–e25351. 38 indexed citations
11.
Reddy, Mamatha M., et al.. (2011). Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia. 26(4). 708–715. 82 indexed citations
12.
Chauhan, Dharminder, Madhavi Bandi, Ajita Singh, et al.. (2011). Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells. British Journal of Haematology. 155(5). 588–598. 53 indexed citations
13.
Weisberg, Ellen, Hwan Geun Choi, Rosemary Barrett, et al.. (2010). Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors. Molecular Cancer Therapeutics. 9(9). 2468–2477. 12 indexed citations
14.
Weisberg, Ellen, Martin Sattler, Arghya Ray, & James D. Griffin. (2010). Drug resistance in mutant FLT3-positive AML. Oncogene. 29(37). 5120–5134. 76 indexed citations
15.
Roesel, Johannes, Pascal Furet, Guido Bold, et al.. (2010). Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison. Genes & Cancer. 1(10). 1021–1032. 33 indexed citations
16.
Weisberg, Ellen, Renee D. Wright, Douglas W. McMillin, et al.. (2008). Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Molecular Cancer Therapeutics. 7(5). 1121–1129. 60 indexed citations
17.
Weisberg, Ellen, Andrew L. Kung, Renee D. Wright, et al.. (2007). Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells. Molecular Cancer Therapeutics. 6(7). 1951–1961. 66 indexed citations
18.
Weisberg, Ellen, Paul W. Manley, J. Mestan, et al.. (2006). AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. British Journal of Cancer. 94(12). 1765–1769. 364 indexed citations
19.
Weisberg, Ellen, Renee D. Wright, Jingrui Jiang, et al.. (2006). Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib Sensitivity. Gastroenterology. 131(6). 1734–1742. 75 indexed citations
20.
Das, Suman, Gopinatha Suresh Kumar, Arghya Ray, & Motilal Maiti. (2003). Spectroscopic and Thermodynamic Studies on the Binding of Sanguinarine and Berberine to Triple and Double Helical DNA and RNA Structures. Journal of Biomolecular Structure and Dynamics. 20(5). 703–713. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darren R. Veach Breakdown of academic impact, for papers by Warren Fiskus Breakdown of academic impact, for papers by Richard L. Momparler Breakdown of academic impact, for papers by Stefan Nagel Breakdown of academic impact, for papers by H. Trent Spencer Breakdown of academic impact, for papers by Arthur J. Chirino Breakdown of academic impact, for papers by Steven Rosenberg Breakdown of academic impact, for papers by Maria G. Pallavicini Breakdown of academic impact, for papers by Staffan Magnusson Breakdown of academic impact, for papers by Robert A. Copeland
Rankless by CCL
2026